Dr. Maria Fardis | President and CEO |
Tim Morris | CFO |
Dr. Igor Gorbatchevsky | VP, Clinical Science |
Joe Pantginis | H.C. Wainwright |
Biren Amin | Jefferies |
Mike Breidenbach | Oppenheimer |
Madhu Kumar | B. Riley FBR |
Good afternoon and welcome to the Iovance Biotherapeutics Fourth Quarter and Year-End 2017 Conference Call. All participants are in a listen-only mode.
Following the formal remarks, we will open the call up for your questions. Please be advised that this call is being recorded at the Company’s request. At this time, I would like to turn the conference over to Tim Morris, Chief Financial Officer at Iovance.